Virtual Clinical Trials Market Size, Share & Trends Analysis Report By Study Design (Interventional, Observational, Expanded Access), By Indication (Oncology, Cardiovascular), By Region, And Segment Forecasts, 2022 - 2030
This report can be delivered to the clients within 72 Business Hours
Virtual Clinical Trials Market Growth & Trends
The global virtual clinical trials market size is expected to reach USD 12.9 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.7% from 2022 to 2030. The COVID-19 pandemic has significantly impacted the market. The growing need for patient diversity clubbed with enhanced data collection in clinical trials is boosting the market growth.
There has been a rise in the R&D of new drugs and vaccines that has increased the volume and complexity of clinical trials. Virtual clinical trials eliminate challenges posed by traditional clinical trials for example delays in patient recruitment and time-consuming procedures. Also, studies have revealed that around 75.0% of people favored a mobile trial over traditional ones and 80.0% of patients are more likely to participate in a clinical trial that uses mobile technology.
The market is recovering at a significant pace after the pandemic as it offers various benefits to patients as well as sponsors. During the pandemic, traveling was potentially dangerous. It can be expensive, even incurring lost wages or requiring that childcare/eldercare be hired. These drawbacks limit initial interest and provide a simple solution for virtual clinical trials. Virtual clinical trials offer various benefits such as effective data collection, analysis, and monitoring large amounts of data in real-time.
Virtual trials make use of monitoring devices, software apps, online social engagement platforms to conduct every step of the clinical trial process including patient recruitment, counseling, measuring clinical endpoints, informed consent, and adverse reactions. Telehealth, home care, and remote patient monitoring has been gaining momentum as a healthcare offering, and the COVID-19 is adding more horsepower to this initiative.
Virtual Clinical Trials Market Report Highlights
Virtual Clinical Trials Market Growth & Trends
The global virtual clinical trials market size is expected to reach USD 12.9 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.7% from 2022 to 2030. The COVID-19 pandemic has significantly impacted the market. The growing need for patient diversity clubbed with enhanced data collection in clinical trials is boosting the market growth.
There has been a rise in the R&D of new drugs and vaccines that has increased the volume and complexity of clinical trials. Virtual clinical trials eliminate challenges posed by traditional clinical trials for example delays in patient recruitment and time-consuming procedures. Also, studies have revealed that around 75.0% of people favored a mobile trial over traditional ones and 80.0% of patients are more likely to participate in a clinical trial that uses mobile technology.
The market is recovering at a significant pace after the pandemic as it offers various benefits to patients as well as sponsors. During the pandemic, traveling was potentially dangerous. It can be expensive, even incurring lost wages or requiring that childcare/eldercare be hired. These drawbacks limit initial interest and provide a simple solution for virtual clinical trials. Virtual clinical trials offer various benefits such as effective data collection, analysis, and monitoring large amounts of data in real-time.
Virtual trials make use of monitoring devices, software apps, online social engagement platforms to conduct every step of the clinical trial process including patient recruitment, counseling, measuring clinical endpoints, informed consent, and adverse reactions. Telehealth, home care, and remote patient monitoring has been gaining momentum as a healthcare offering, and the COVID-19 is adding more horsepower to this initiative.
Virtual Clinical Trials Market Report Highlights
- The oncology segment held 25.2% of the revenue share in 2021. The increasing adoption of virtual trials especially in oncology clinical research for the diverse populations is responsible for the growth of the segment
- The interventional design segment accounted for the largest revenue share of 46.7% in 2021
- North America held 49.2% of the revenue share in 2021. Favorable government initiatives and the presence of large numbers of players in the U.S. offerings advanced services are responsible for market growth
- In Asia Pacific, the market is expected to witness the fastest CAGR of 6.8% over the forecast period owing to the increasing patient pool and cost-efficient services
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.1.1. Study design
1.1.2. Indication
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1: Understanding the market dynamics
1.9.2. Objective 2: Understanding the market estimates and forecasts
1.9.3. Objective 3: Understanding the attributes such as strategy framework, competitor categorization
1.9.4. Objective 4: Understanding the key product and application scopes to conclude on the market size
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. VIRTUAL/DECENTRALIZED CLINICAL TRIALS MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. COVID-19 pandemic impact on clinical trial activity
3.4. Market Dynamics
3.4.1. Market Driver Analysis
3.4.1.1. The growing role technology in the healthcare
3.4.1.2. Benefits of virtual trials
3.4.1.3. Government support
3.4.2. Market Restraint Analysis
3.4.2.1. Data Security
3.4.3. Industry Challenge
3.5. Virtual/Decentralized Clinical Trials: Market Analysis Tools
3.5.1. Industry Analysis – Porter’s
3.5.1.1. Supplier Power
3.5.1.2. Buyer Power
3.5.1.3. Substitution Threat
3.5.1.4. Threat from new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
CHAPTER 4. VIRTUAL/DECENTRALIZED CLINICAL TRIALS MARKET: SEGMENT ANALYSIS, BY STUDY DESIGN, 2017 - 2030 (USD MILLION)
4.1. Segment Dashboard
4.2. Study Design Market Share Analysis, 2020 & 2030
4.3. Global Virtual/Decentralized Clinical Trials Market, By Study Design, 2017 to 2030
4.4. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
4.4.1. Interventional
4.4.2. Observational
4.4.3. Expanded Access
CHAPTER 5. VIRTUAL/DECENTRALIZED CLINICAL TRIALS MARKET: SEGMENT ANALYSIS, BY INDICATION, 2017 - 2030 (USD MILLION)
5.1. Segment Dashboard
5.2. Indication Market Share Analysis, 2020 & 2030
5.3. Global Virtual/Decentralized Clinical Trials Market, By Cancer Type, 2017 to 2030
5.4. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
5.4.1. Oncology
5.4.2. Cardiovascular
5.4.3. Others
CHAPTER 6. VIRTUAL/DECENTRALIZED CLINICAL TRIALS MARKET: REGIONAL MARKET ANALYSIS, BY STUDY DESIGN, 2017 - 2030 (USD MILLION)
6.1. Regional Market Dashboard
6.2. Regional Market Share Analysis, 2020 & 2030
6.3. Market Size, & Forecasts, and Trend Analysis, 2017 to 2030:
6.4. North America
6.4.1. Market estimates and forecast, by country, 2017 - 2030 (USD Million)
6.4.2. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
6.4.3. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
6.4.4. U.S.
6.4.4.1. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
6.4.4.2. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
6.4.5. Canada
6.4.5.1. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
6.4.5.2. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
6.5. Europe
6.5.1. Market estimates and forecast, by country, 2017 - 2030 (USD Million)
6.5.2. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
6.5.3. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
6.5.4. Germany
6.5.4.1. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
6.5.4.2. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
6.5.5. U.K.
6.5.5.1. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
6.5.5.2. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
6.5.6. France
6.5.6.1. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
6.5.6.2. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
6.5.7. Italy
6.5.7.1. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
6.5.7.2. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
6.5.8. Spain
6.5.8.1. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
6.5.8.2. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
6.6. Asia Pacific
6.6.1. Market estimates and forecast, by country, 2017 - 2030 (USD Million)
6.6.2. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
6.6.3. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
6.6.4. India
6.6.4.1. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
6.6.4.2. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
6.6.5. Japan
6.6.5.1. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
6.6.5.2. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
6.6.6. China
6.6.6.1. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
6.6.6.2. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
6.6.7. Australia
6.6.7.1. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
6.6.7.2. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
6.6.8. South Korea
6.6.8.1. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
6.6.8.2. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
6.7. Latin America
6.7.1. Market estimates and forecast, by country, 2017 - 2030 (USD Million)
6.7.2. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
6.7.3. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
6.7.4. Brazil
6.7.4.1. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
6.7.4.2. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
6.7.5. Mexico
6.7.5.1. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
6.7.5.2. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
6.7.6. Argentina
6.7.6.1. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
6.7.6.2. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
6.7.7. Colombia
6.7.7.1. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
6.7.7.2. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
6.8. Middle East and Africa
6.8.1. Market estimates and forecast, by country, 2017 - 2030 (USD Million)
6.8.2. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
6.8.3. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
6.8.4. South Africa
6.8.4.1. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
6.8.4.2. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
6.8.5. Saudi Arabia
6.8.5.1. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
6.8.5.2. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
6.8.6. UAE
6.8.6.1. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
6.8.6.2. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
CHAPTER 7. VIRTUAL/DECENTRALIZED CLINICAL TRIALS MARKET– COMPETITIVE ANALYSIS
7.1. Key companies profiled
7.1.1. ICON, plc
7.1.1.1. Company Overview
7.1.1.2. Financial Performance
7.1.1.3. Product Benchmarking
7.1.1.4. Strategic Initiatives
7.1.2. PAREXEL International Corporation
7.1.2.1. Company Overview
7.1.2.2. Financial Performance
7.1.2.3. Product Benchmarking
7.1.2.4. Strategic Initiatives
7.1.3. IQVIA
7.1.3.1. Company Overview
7.1.3.2. Financial Performance
7.1.3.3. Product Benchmarking
7.1.3.4. Strategic Initiatives
7.1.4. Covance
7.1.4.1. Company Overview
7.1.4.2. Financial Performance
7.1.4.3. Product Benchmarking
7.1.4.4. Strategic Initiatives
7.1.5. PRA Health Sciences
7.1.5.1. Company Overview
7.1.5.2. Financial Performance
7.1.5.3. Product Benchmarking
7.1.5.4. Strategic Initiatives
7.1.6. LEO Innovation Lab
7.1.6.1. Company Overview
7.1.6.2. Financial Performance
7.1.6.3. Product Benchmarking
7.1.6.4. Strategic Initiatives
7.1.7. Medidata
7.1.7.1. Company Overview
7.1.7.2. Financial Performance
7.1.7.3. Product Benchmarking
7.1.7.4. Strategic Initiatives
7.1.8. Oracle
7.1.8.1. Company Overview
7.1.8.2. Financial Performance
7.1.8.3. Product Benchmarking
7.1.8.4. Strategic Initiatives
7.1.9. CRF Health
7.1.9.1. Company Overview
7.1.9.2. Financial Performance
7.1.9.3. Product Benchmarking
7.1.9.4. Strategic Initiatives
7.1.10. Clinical Ink
7.1.10.1. Company Overview
7.1.10.2. Financial Performance
7.1.10.3. Product Benchmarking
7.1.10.4. Strategic Initiatives
7.1.11. Medable Inc.
7.1.11.1. Company Overview
7.1.11.2. Financial Performance
7.1.11.3. Product Benchmarking
7.1.11.4. Strategic Initiatives
1.1. Market Segmentation & Scope
1.1.1. Study design
1.1.2. Indication
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1: Understanding the market dynamics
1.9.2. Objective 2: Understanding the market estimates and forecasts
1.9.3. Objective 3: Understanding the attributes such as strategy framework, competitor categorization
1.9.4. Objective 4: Understanding the key product and application scopes to conclude on the market size
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. VIRTUAL/DECENTRALIZED CLINICAL TRIALS MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. COVID-19 pandemic impact on clinical trial activity
3.4. Market Dynamics
3.4.1. Market Driver Analysis
3.4.1.1. The growing role technology in the healthcare
3.4.1.2. Benefits of virtual trials
3.4.1.3. Government support
3.4.2. Market Restraint Analysis
3.4.2.1. Data Security
3.4.3. Industry Challenge
3.5. Virtual/Decentralized Clinical Trials: Market Analysis Tools
3.5.1. Industry Analysis – Porter’s
3.5.1.1. Supplier Power
3.5.1.2. Buyer Power
3.5.1.3. Substitution Threat
3.5.1.4. Threat from new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
CHAPTER 4. VIRTUAL/DECENTRALIZED CLINICAL TRIALS MARKET: SEGMENT ANALYSIS, BY STUDY DESIGN, 2017 - 2030 (USD MILLION)
4.1. Segment Dashboard
4.2. Study Design Market Share Analysis, 2020 & 2030
4.3. Global Virtual/Decentralized Clinical Trials Market, By Study Design, 2017 to 2030
4.4. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
4.4.1. Interventional
4.4.2. Observational
4.4.3. Expanded Access
CHAPTER 5. VIRTUAL/DECENTRALIZED CLINICAL TRIALS MARKET: SEGMENT ANALYSIS, BY INDICATION, 2017 - 2030 (USD MILLION)
5.1. Segment Dashboard
5.2. Indication Market Share Analysis, 2020 & 2030
5.3. Global Virtual/Decentralized Clinical Trials Market, By Cancer Type, 2017 to 2030
5.4. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
5.4.1. Oncology
5.4.2. Cardiovascular
5.4.3. Others
CHAPTER 6. VIRTUAL/DECENTRALIZED CLINICAL TRIALS MARKET: REGIONAL MARKET ANALYSIS, BY STUDY DESIGN, 2017 - 2030 (USD MILLION)
6.1. Regional Market Dashboard
6.2. Regional Market Share Analysis, 2020 & 2030
6.3. Market Size, & Forecasts, and Trend Analysis, 2017 to 2030:
6.4. North America
6.4.1. Market estimates and forecast, by country, 2017 - 2030 (USD Million)
6.4.2. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
6.4.3. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
6.4.4. U.S.
6.4.4.1. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
6.4.4.2. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
6.4.5. Canada
6.4.5.1. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
6.4.5.2. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
6.5. Europe
6.5.1. Market estimates and forecast, by country, 2017 - 2030 (USD Million)
6.5.2. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
6.5.3. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
6.5.4. Germany
6.5.4.1. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
6.5.4.2. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
6.5.5. U.K.
6.5.5.1. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
6.5.5.2. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
6.5.6. France
6.5.6.1. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
6.5.6.2. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
6.5.7. Italy
6.5.7.1. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
6.5.7.2. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
6.5.8. Spain
6.5.8.1. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
6.5.8.2. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
6.6. Asia Pacific
6.6.1. Market estimates and forecast, by country, 2017 - 2030 (USD Million)
6.6.2. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
6.6.3. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
6.6.4. India
6.6.4.1. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
6.6.4.2. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
6.6.5. Japan
6.6.5.1. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
6.6.5.2. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
6.6.6. China
6.6.6.1. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
6.6.6.2. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
6.6.7. Australia
6.6.7.1. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
6.6.7.2. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
6.6.8. South Korea
6.6.8.1. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
6.6.8.2. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
6.7. Latin America
6.7.1. Market estimates and forecast, by country, 2017 - 2030 (USD Million)
6.7.2. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
6.7.3. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
6.7.4. Brazil
6.7.4.1. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
6.7.4.2. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
6.7.5. Mexico
6.7.5.1. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
6.7.5.2. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
6.7.6. Argentina
6.7.6.1. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
6.7.6.2. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
6.7.7. Colombia
6.7.7.1. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
6.7.7.2. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
6.8. Middle East and Africa
6.8.1. Market estimates and forecast, by country, 2017 - 2030 (USD Million)
6.8.2. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
6.8.3. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
6.8.4. South Africa
6.8.4.1. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
6.8.4.2. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
6.8.5. Saudi Arabia
6.8.5.1. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
6.8.5.2. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
6.8.6. UAE
6.8.6.1. Market estimates and forecast, by study design, 2017 - 2030 (USD Million)
6.8.6.2. Market estimates and forecast, by indication, 2017 - 2030 (USD Million)
CHAPTER 7. VIRTUAL/DECENTRALIZED CLINICAL TRIALS MARKET– COMPETITIVE ANALYSIS
7.1. Key companies profiled
7.1.1. ICON, plc
7.1.1.1. Company Overview
7.1.1.2. Financial Performance
7.1.1.3. Product Benchmarking
7.1.1.4. Strategic Initiatives
7.1.2. PAREXEL International Corporation
7.1.2.1. Company Overview
7.1.2.2. Financial Performance
7.1.2.3. Product Benchmarking
7.1.2.4. Strategic Initiatives
7.1.3. IQVIA
7.1.3.1. Company Overview
7.1.3.2. Financial Performance
7.1.3.3. Product Benchmarking
7.1.3.4. Strategic Initiatives
7.1.4. Covance
7.1.4.1. Company Overview
7.1.4.2. Financial Performance
7.1.4.3. Product Benchmarking
7.1.4.4. Strategic Initiatives
7.1.5. PRA Health Sciences
7.1.5.1. Company Overview
7.1.5.2. Financial Performance
7.1.5.3. Product Benchmarking
7.1.5.4. Strategic Initiatives
7.1.6. LEO Innovation Lab
7.1.6.1. Company Overview
7.1.6.2. Financial Performance
7.1.6.3. Product Benchmarking
7.1.6.4. Strategic Initiatives
7.1.7. Medidata
7.1.7.1. Company Overview
7.1.7.2. Financial Performance
7.1.7.3. Product Benchmarking
7.1.7.4. Strategic Initiatives
7.1.8. Oracle
7.1.8.1. Company Overview
7.1.8.2. Financial Performance
7.1.8.3. Product Benchmarking
7.1.8.4. Strategic Initiatives
7.1.9. CRF Health
7.1.9.1. Company Overview
7.1.9.2. Financial Performance
7.1.9.3. Product Benchmarking
7.1.9.4. Strategic Initiatives
7.1.10. Clinical Ink
7.1.10.1. Company Overview
7.1.10.2. Financial Performance
7.1.10.3. Product Benchmarking
7.1.10.4. Strategic Initiatives
7.1.11. Medable Inc.
7.1.11.1. Company Overview
7.1.11.2. Financial Performance
7.1.11.3. Product Benchmarking
7.1.11.4. Strategic Initiatives
LIST OF TABLES
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Virtual/Decentralized Clinical Trials Market, By Region, 2017 - 2030 (USD Million)
Table 4 Global Virtual/Decentralized Clinical Trials Market, By Study Design, 2017 - 2030 (USD Million)
Table 5 Global Virtual/Decentralized Clinical Trials Market, By Indication, 2017 - 2030 (USD Million)
Table 6 North America Virtual/Decentralized Clinical Trials Market, By Country, 2017 - 2030 (USD Million)
Table 7 North America Virtual/Decentralized Clinical Trials Market, By Study Design, 2017 - 2030 (USD Million)
Table 8 North America Virtual/Decentralized Clinical Trials Market, By Indication, 2017 - 2030 (USD Million)
Table 9 U.S. Virtual/Decentralized Clinical Trials Market, By Study Design, 2017 - 2030 (USD Million)
Table 10 U.S. Virtual/Decentralized Clinical Trials Market, By Indication, 2017 - 2030 (USD Million)
Table 11 Canada Virtual/Decentralized Clinical Trials Market, By Study Design, 2017 - 2030 (USD Million)
Table 12 Canada Virtual/Decentralized Clinical Trials Market, By Indication, 2017 - 2030 (USD Million)
Table 13 Europe Virtual/Decentralized Clinical Trials Market, By Country, 2017 - 2030 (USD Million)
Table 14 Europe Virtual/Decentralized Clinical Trials Market, By Study Design, 2017 - 2030 (USD Million)
Table 15 Europe Virtual/Decentralized Clinical Trials Market, By Indication, 2017 - 2030 (USD Million)
Table 16 U.K. Virtual Clinical/Decentralized Trials Market, By Study Design, 2017 - 2030 (USD Million)
Table 17 U.K. Virtual Clinical/Decentralized Trials Market, By Indication, 2017 - 2030 (USD Million)
Table 18 Germany Virtual/Decentralized Clinical Trials Market, By Study Design, 2017 - 2030 (USD Million)
Table 19 Germany Virtual/Decentralized Clinical Trials Market, By Indication, 2017 - 2030 (USD Million)
Table 20 France Virtual/Decentralized Clinical Trials Market, By Study Design, 2017 - 2030 (USD Million)
Table 21 France Virtual/Decentralized Clinical Trials Market, By Indication, 2017 - 2030 (USD Million)
Table 22 Italy Virtual/Decentralized Clinical Trials Market, By Study Design, 2017 - 2030 (USD Million)
Table 23 Italy Virtual/Decentralized Clinical Trials Market, By Indication, 2017 - 2030 (USD Million)
Table 24 Spain Virtual/Decentralized Clinical Trials Market, By Study Design, 2017 - 2030 (USD Million)
Table 25 Spain Virtual/Decentralized Clinical Trials Market, By Indication, 2017 - 2030 (USD Million)
Table 26 Asia Pacific Virtual/Decentralized Clinical Trials Market, By Country, 2017 - 2030 (USD Million)
Table 27 Asia Pacific Virtual/Decentralized Clinical Trials Market, By Study Design, 2017 - 2030 (USD Million)
Table 28 Asia Pacific Virtual/Decentralized Clinical Trials Market, By Indication, 2017 - 2030 (USD Million)
Table 29 India Virtual/Decentralized Clinical Trials Market, By Study Design, 2017 - 2030 (USD Million)
Table 30 India Virtual/Decentralized Clinical Trials Market, By Indication, 2017 - 2030 (USD Million)
Table 31 Japan Virtual/Decentralized Clinical Trials Market, By Study Design, 2017 - 2030 (USD Million)
Table 32 Japan Virtual/Decentralized Clinical Trials Market, By Indication, 2017 - 2030 (USD Million)
Table 33 China Virtual/Decentralized Clinical Trials Market, By Study Design, 2017 - 2030 (USD Million)
Table 34 China Virtual/Decentralized Clinical Trials Market, By Indication, 2017 - 2030 (USD Million)
Table 35 Australia Virtual/Decentralized Clinical Trials Market, By Study Design, 2017 - 2030 (USD Million)
Table 36 Australia Virtual/Decentralized Clinical Trials Market, By Indication, 2017 - 2030 (USD Million)
Table 37 South Korea Virtual/Decentralized Clinical Trials Market, By Study Design, 2017 - 2030 (USD Million)
Table 38 South Korea Virtual/Decentralized Clinical Trials Market, By Indication, 2017 - 2030 (USD Million)
Table 39 Latin America Virtual/Decentralized Clinical Trials Market, By Country, 2017 - 2030 (USD Million)
Table 40 Latin America Virtual/Decentralized Clinical Trials Market, By Study Design, 2017 - 2030 (USD Million)
Table 41 Latin America Virtual/Decentralized Clinical Trials Market, By Indication, 2017 - 2030 (USD Million)
Table 42 Brazil Virtual/Decentralized Clinical Trials Market, By Study Design, 2017 - 2030 (USD Million)
Table 43 Brazil Virtual/Decentralized Clinical Trials Market, By Indication, 2017 - 2030 (USD Million)
Table 44 Mexico Virtual/Decentralized Clinical Trials Market, By Study Design, 2017 - 2030 (USD Million)
Table 45 Mexico Virtual/Decentralized Clinical Trials Market, By Indication, 2017 - 2030 (USD Million)
Table 46 Argentina Virtual/Decentralized Clinical Trials Market, By Study Design, 2017 - 2030 (USD Million)
Table 47 Argentina Virtual/Decentralized Clinical Trials Market, By Indication, 2017 - 2030 (USD Million)
Table 48 Colombia Virtual/Decentralized Clinical Trials Market, By Study Design, 2017 - 2030 (USD Million)
Table 49 Colombia Virtual/Decentralized Clinical Trials Market, By Indication, 2017 - 2030 (USD Million)
Table 50 MEA Virtual/Decentralized Clinical Trials Market, By Country, 2017 - 2030 (USD Million)
Table 51 MEA Virtual/Decentralized Clinical Trials Market, By Study Design, 2017 - 2030 (USD Million)
Table 52 MEA Virtual/Decentralized Clinical Trials Market, By Indication, 2017 - 2030 (USD Million)
Table 53 South Africa Virtual/Decentralized Clinical Trials Market, By Study Design, 2017 - 2030 (USD Million)
Table 54 South Africa Virtual/Decentralized Clinical Trials Market, By Indication, 2017 - 2030 (USD Million)
Table 55 Saudi Arabia Virtual/Decentralized Clinical Trials Market, By Study Design, 2017 - 2030 (USD Million)
Table 56 Saudi Arabia Virtual/Decentralized Clinical Trials Market, By Indication, 2017 - 2030 (USD Million)
Table 57 UAE Virtual/Decentralized Clinical Trials Market, By Study Design, 2017 - 2030 (USD Million)
Table 58 UAE Virtual/Decentralized Clinical Trials Market, By Indication, 2017 - 2030 (USD Million)
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Virtual/Decentralized Clinical Trials Market, By Region, 2017 - 2030 (USD Million)
Table 4 Global Virtual/Decentralized Clinical Trials Market, By Study Design, 2017 - 2030 (USD Million)
Table 5 Global Virtual/Decentralized Clinical Trials Market, By Indication, 2017 - 2030 (USD Million)
Table 6 North America Virtual/Decentralized Clinical Trials Market, By Country, 2017 - 2030 (USD Million)
Table 7 North America Virtual/Decentralized Clinical Trials Market, By Study Design, 2017 - 2030 (USD Million)
Table 8 North America Virtual/Decentralized Clinical Trials Market, By Indication, 2017 - 2030 (USD Million)
Table 9 U.S. Virtual/Decentralized Clinical Trials Market, By Study Design, 2017 - 2030 (USD Million)
Table 10 U.S. Virtual/Decentralized Clinical Trials Market, By Indication, 2017 - 2030 (USD Million)
Table 11 Canada Virtual/Decentralized Clinical Trials Market, By Study Design, 2017 - 2030 (USD Million)
Table 12 Canada Virtual/Decentralized Clinical Trials Market, By Indication, 2017 - 2030 (USD Million)
Table 13 Europe Virtual/Decentralized Clinical Trials Market, By Country, 2017 - 2030 (USD Million)
Table 14 Europe Virtual/Decentralized Clinical Trials Market, By Study Design, 2017 - 2030 (USD Million)
Table 15 Europe Virtual/Decentralized Clinical Trials Market, By Indication, 2017 - 2030 (USD Million)
Table 16 U.K. Virtual Clinical/Decentralized Trials Market, By Study Design, 2017 - 2030 (USD Million)
Table 17 U.K. Virtual Clinical/Decentralized Trials Market, By Indication, 2017 - 2030 (USD Million)
Table 18 Germany Virtual/Decentralized Clinical Trials Market, By Study Design, 2017 - 2030 (USD Million)
Table 19 Germany Virtual/Decentralized Clinical Trials Market, By Indication, 2017 - 2030 (USD Million)
Table 20 France Virtual/Decentralized Clinical Trials Market, By Study Design, 2017 - 2030 (USD Million)
Table 21 France Virtual/Decentralized Clinical Trials Market, By Indication, 2017 - 2030 (USD Million)
Table 22 Italy Virtual/Decentralized Clinical Trials Market, By Study Design, 2017 - 2030 (USD Million)
Table 23 Italy Virtual/Decentralized Clinical Trials Market, By Indication, 2017 - 2030 (USD Million)
Table 24 Spain Virtual/Decentralized Clinical Trials Market, By Study Design, 2017 - 2030 (USD Million)
Table 25 Spain Virtual/Decentralized Clinical Trials Market, By Indication, 2017 - 2030 (USD Million)
Table 26 Asia Pacific Virtual/Decentralized Clinical Trials Market, By Country, 2017 - 2030 (USD Million)
Table 27 Asia Pacific Virtual/Decentralized Clinical Trials Market, By Study Design, 2017 - 2030 (USD Million)
Table 28 Asia Pacific Virtual/Decentralized Clinical Trials Market, By Indication, 2017 - 2030 (USD Million)
Table 29 India Virtual/Decentralized Clinical Trials Market, By Study Design, 2017 - 2030 (USD Million)
Table 30 India Virtual/Decentralized Clinical Trials Market, By Indication, 2017 - 2030 (USD Million)
Table 31 Japan Virtual/Decentralized Clinical Trials Market, By Study Design, 2017 - 2030 (USD Million)
Table 32 Japan Virtual/Decentralized Clinical Trials Market, By Indication, 2017 - 2030 (USD Million)
Table 33 China Virtual/Decentralized Clinical Trials Market, By Study Design, 2017 - 2030 (USD Million)
Table 34 China Virtual/Decentralized Clinical Trials Market, By Indication, 2017 - 2030 (USD Million)
Table 35 Australia Virtual/Decentralized Clinical Trials Market, By Study Design, 2017 - 2030 (USD Million)
Table 36 Australia Virtual/Decentralized Clinical Trials Market, By Indication, 2017 - 2030 (USD Million)
Table 37 South Korea Virtual/Decentralized Clinical Trials Market, By Study Design, 2017 - 2030 (USD Million)
Table 38 South Korea Virtual/Decentralized Clinical Trials Market, By Indication, 2017 - 2030 (USD Million)
Table 39 Latin America Virtual/Decentralized Clinical Trials Market, By Country, 2017 - 2030 (USD Million)
Table 40 Latin America Virtual/Decentralized Clinical Trials Market, By Study Design, 2017 - 2030 (USD Million)
Table 41 Latin America Virtual/Decentralized Clinical Trials Market, By Indication, 2017 - 2030 (USD Million)
Table 42 Brazil Virtual/Decentralized Clinical Trials Market, By Study Design, 2017 - 2030 (USD Million)
Table 43 Brazil Virtual/Decentralized Clinical Trials Market, By Indication, 2017 - 2030 (USD Million)
Table 44 Mexico Virtual/Decentralized Clinical Trials Market, By Study Design, 2017 - 2030 (USD Million)
Table 45 Mexico Virtual/Decentralized Clinical Trials Market, By Indication, 2017 - 2030 (USD Million)
Table 46 Argentina Virtual/Decentralized Clinical Trials Market, By Study Design, 2017 - 2030 (USD Million)
Table 47 Argentina Virtual/Decentralized Clinical Trials Market, By Indication, 2017 - 2030 (USD Million)
Table 48 Colombia Virtual/Decentralized Clinical Trials Market, By Study Design, 2017 - 2030 (USD Million)
Table 49 Colombia Virtual/Decentralized Clinical Trials Market, By Indication, 2017 - 2030 (USD Million)
Table 50 MEA Virtual/Decentralized Clinical Trials Market, By Country, 2017 - 2030 (USD Million)
Table 51 MEA Virtual/Decentralized Clinical Trials Market, By Study Design, 2017 - 2030 (USD Million)
Table 52 MEA Virtual/Decentralized Clinical Trials Market, By Indication, 2017 - 2030 (USD Million)
Table 53 South Africa Virtual/Decentralized Clinical Trials Market, By Study Design, 2017 - 2030 (USD Million)
Table 54 South Africa Virtual/Decentralized Clinical Trials Market, By Indication, 2017 - 2030 (USD Million)
Table 55 Saudi Arabia Virtual/Decentralized Clinical Trials Market, By Study Design, 2017 - 2030 (USD Million)
Table 56 Saudi Arabia Virtual/Decentralized Clinical Trials Market, By Indication, 2017 - 2030 (USD Million)
Table 57 UAE Virtual/Decentralized Clinical Trials Market, By Study Design, 2017 - 2030 (USD Million)
Table 58 UAE Virtual/Decentralized Clinical Trials Market, By Indication, 2017 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Virtual/decentralized clinical trials market: Market snapshot
Fig. 9 Virtual/decentralized clinical trials market: Market segmentation
Fig. 10 Virtual/decentralized clinical trials market strategy framework
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Virtual/decentralized clinical trials market driver impact
Fig. 14 Virtual/decentralized clinical trials market restraint impact
Fig. 15 Virtual/decentralized clinical trials market porter’s five forces analysis
Fig. 16 Virtual/decentralized clinical trials market PESTEL analysis
Fig. 17 Virtual/decentralized clinical trials market: study design segment dashboard
Fig. 18 Virtual/decentralized clinical trials market: Study design movement analysis
Fig. 19 Interventional market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 20 Observational market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 21 Expanded Access market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 22 Virtual/decentralized clinical trials market: Segment dashboard
Fig. 23 Virtual/decentralized clinical trials market: Indication movement analysis
Fig. 24 virtual/decentralized market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 25 Cardiovascular market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 26 Others market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 27 Global virtual/decentralized clinical trials market: Regional movement analysis
Fig. 28 Global virtual/decentralized clinical trials market: Regional outlook and key takeaways
Fig. 29 North America market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 30 U.S. market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 31 Canada market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 32 Europe market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 33 U.K. market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 34 Germany market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 35 France market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 36 Italy market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 37 Spain market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 38 Asia Pacific market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 39 India market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 40 Japan market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 41 China market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 42 Australia market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 43 South Korea market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 44 Latin America market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 45 Brazil market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 46 Mexico market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 47 Argentina market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 48 Colombia market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 49 Middle East and Africa. market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 50 South Africa market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 51 Saudi Arabia market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 52 UAE market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Virtual/decentralized clinical trials market: Market snapshot
Fig. 9 Virtual/decentralized clinical trials market: Market segmentation
Fig. 10 Virtual/decentralized clinical trials market strategy framework
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Virtual/decentralized clinical trials market driver impact
Fig. 14 Virtual/decentralized clinical trials market restraint impact
Fig. 15 Virtual/decentralized clinical trials market porter’s five forces analysis
Fig. 16 Virtual/decentralized clinical trials market PESTEL analysis
Fig. 17 Virtual/decentralized clinical trials market: study design segment dashboard
Fig. 18 Virtual/decentralized clinical trials market: Study design movement analysis
Fig. 19 Interventional market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 20 Observational market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 21 Expanded Access market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 22 Virtual/decentralized clinical trials market: Segment dashboard
Fig. 23 Virtual/decentralized clinical trials market: Indication movement analysis
Fig. 24 virtual/decentralized market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 25 Cardiovascular market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 26 Others market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 27 Global virtual/decentralized clinical trials market: Regional movement analysis
Fig. 28 Global virtual/decentralized clinical trials market: Regional outlook and key takeaways
Fig. 29 North America market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 30 U.S. market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 31 Canada market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 32 Europe market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 33 U.K. market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 34 Germany market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 35 France market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 36 Italy market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 37 Spain market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 38 Asia Pacific market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 39 India market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 40 Japan market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 41 China market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 42 Australia market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 43 South Korea market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 44 Latin America market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 45 Brazil market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 46 Mexico market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 47 Argentina market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 48 Colombia market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 49 Middle East and Africa. market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 50 South Africa market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 51 Saudi Arabia market estimates and forecast, 2017 - 2030 (USD Million)
Fig. 52 UAE market estimates and forecast, 2017 - 2030 (USD Million)
